The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish Cohort.

Saved in:
Bibliographic Details
Title: The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish Cohort.
Authors: Athanasiou, Alcibiade1 (AUTHOR), Hansen, Torben F.2,3 (AUTHOR), Madsen, Jonna S.3,4 (AUTHOR), Poulsen, Mads H.3,4,5 (AUTHOR), Mortensen, Mike Allan5,6 (AUTHOR), Kissow, Gitte E.6,7 (AUTHOR), Øbro, Louise F.3,7 (AUTHOR), Osther, Palle J.1,3,7 (AUTHOR), Schiess, Ralph1,2 (AUTHOR), Zedan, Ahmed H.2,3 (AUTHOR) ahmed.zedan@rsyd.dk
Source: Cancers. May2026, Vol. 18 Issue 9, p1348. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18091348